Fiera Capital Corp Catalent, Inc. Transaction History

Fiera Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$29.95 - $46.34 $2.41 Million - $3.73 Million	-80,520 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $2 Million - $2.27 Million	-49,815 Reduced 38.22%	80,520 $3.67 Million
Q2 2018 Aug 02, 2018	SELL	$38.72 - $42.52 $423,829 - $465,423	-10,946 Reduced 7.75%	130,335 $5.46 Million
Q1 2018 May 11, 2018	SELL	$39.4 - $47.39 $719,483 - $865,388	-18,261 Reduced 11.45%	141,281 $5.8 Million
Q4 2017 Feb 09, 2018	BUY	$37.27 - $43.02 $5.95 Million - $6.86 Million	159,542	159,542 $6.55 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.